. Author manuscript; available in PMC: 2015 Jul 9.

Published in final edited form as: Gynecol Oncol. 2011 Oct 13;124(1):48–52. doi: 10.1016/j.ygyno.2011.09.019

Table 1.

Targeted accrual and decision guidelines by stage of accrual

Stage of Accrual	Targeted Cumulative Accrual	Limits of Actual Accrual	Max Number of Responses to Reject H₁ (conclude response rate <10%)
1	17	12–19	1/(12–14), 2/(15–19)
2	40	36–43	6/(36 to 39), 7/(40 to 43)